The company invested in a new Good Manufacturing Practice (GMP) facility located at the Mont-sur-Lausanne (Switzerland) beginning production in 2009.

To date, Regen Lab’s patented technologies are available in over 160 countries worldwide, and have been used to treat over 2 million patients in various therapeutic areas (musculoskeletal, dermal, wound care and intimacy) leading to the publication of over 120 research projects.

How do your services benefit Healthcare Professionals to serve menopausal patients?

There is growing interest in the use of several innovative technologies being routinely used for facial skin care and skin rejuvenation for the treatment of genital disorders resulting from the aging process or with inflammation-related origins. This includes the use of PRP.